medium and high-dose methotrexate-induced toxicity in children with acute lymphoblastic leukemia

Authors

zangooei r

hedayati asl aa

vossough p

mehrvar a

abstract

background: methotrexate has an important role in treatment of acute leukemia. we measured methotrexate level in csf and blood of children with acute lymphoblastic leukemia to determine complications and outcomes. materials and methods: one hundred and twenty patients (73 male, 47 female), with mean age at diagnosis of 6.1 years (11mo_15years) entered the study. patients were divided into two groups receiving consolidation therapy of medium-dose mtx 2g/m2/24hrs, or high- dose mtx 5g/m2/24hrs respectively. clinical features, concentration and pharmacokinetic parameters of mtx, as well as serum creatinine were assessed. results: the mean serum mtx levels (24 hours after therapy) was 8.9_ 9.8 µmol/l after 4 courses. the mean serum mtx level 48 hours after therapy was 0.3-0.42 µmol/l after 4 courses. the mean csf mtx levels after therapy was 0.22 µmol/l. the mean serum creatinine before and after mtx therapy were not different between two groups. mucositis was observed as grade 0 in 65.8%, grade 1 in 15%, grade 2in 15%, grade 3 in 3.3% and grade 4 in 0.8% of patients. cns relapse was observed in 20.8% patients. the mean mtx level after 24 hours in patients with cns relapse were lower than the mean mtx level in patients with no cns relapse. mortality in patients with severe mucositis was higher than patients with mild mucositis (p value <.001). mortality in patients with cns relapse was greater than patients without cns relapse. conclusion: routine assessment of the serum mtx levels for medium dose mtx is not necessary, however, careful clinical monitoring of these patient is mandatory. monitoring the plasma concentration of mtx is necessary in high dose mtx therapy. keywords: leukemia, treatment, side effect, methotrexate

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Medium and High-Dose Methotrexate-Induced Toxicity in Children with Acute Lymphoblastic Leukemia

Background: Methotrexate has an important role in treatment of acute leukemia. We measured methotrexate level in CSF and blood of children with acute lymphoblastic leukemia to determine complications and outcomes. Materials and Methods: One hundred and twenty patients (73 male, 47 female), with mean age at diagnosis of 6.1 years (11mo_15years) entered the study. Patients were divided into two...

full text

Monitoring and treatment of acute kidney injury in children with acute lymphoblastic leukemia after high dose methotrexate chemotherapy

Abstact:objective To investigate acute kidney injury (AKI) in children with acute lymphoblastic leukemia (ALL) who received high dose methotrexate (MTX) chemotherapy and explore the corresponding treatment. Methods 180 children who received high dose MTX chemotherapy were observed with serum MTX concentration and serum creatinine. Patients with AKI of stage 3 or poor response to conventional tr...

full text

Monitoring and treatment of acute kidney injury in children with acute lymphoblastic leukemia after high dose methotrexate chemotherapy

Abstact:objective To investigate acute kidney injury (AKI) in children with acute lymphoblastic leukemia (ALL) who received high dose methotrexate (MTX) chemotherapy and explore the corresponding treatment. Methods 180 children who received high dose MTX chemotherapy were observed with serum MTX concentration and serum creatinine. Patients with AKI of stage 3 or poor response to conventional tr...

full text

Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate.

BACKGROUND AND PURPOSE An effective treatment for acute lymphoblastic leukemia (ALL), intravenous (IV) methotrexate (MTX) has a notable toxic effect on the CNS, with leukoencephalopathy (LE) being the most common form. The purpose of this study was to use objective quantitative MR imaging to prospectively assess potential risk factors on the temporal evolution of LE in patients treated for ALL....

full text

Methotrexate Induced Encephalopathy in Acute Lymphoblastic Leukemia in Omani Children

Survival rates for children with leukemia have increased dramatically over the past few decades. Development of new chemotherapeutic agents and expanded use of older agents have had a major impact on outcome. Methotrexate (MTX) was one of the first drugs discovered to have significant activity against leukemia and still continues as a major component of treatment for acute lymphoblastic leukemi...

full text

Polymorphisms within methotrexate pathway genes: Relationship between plasma methotrexate levels, toxicity experienced and outcome in pediatric acute lymphoblastic leukemia

Objective(s): The current study aimed to investigate the relationship of genetic polymorphism and plasma methotrexate (MTX) levels, toxicity experience and event free survival (EFS) in pediatric acute lymphoblastic leukemia (ALL). Materials and Methods: The study included 74 ALL patients. Polymerase chain reaction and genotyping of methy...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of blood and cancer

جلد ۵، شماره ۱، صفحات ۱۹-۲۳

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023